Back to Directory
Aparna Bio
East of England
Founded 2025
ENTECH platform for cell perturbation and AI target discovery
Aparna Bio develops technologies for generating biologically relevant cell-perturbation data to support drug target discovery.
Its ENTECH platform is being engineered to deliver experimental perturbation reagents into primary human cells and other disease-relevant models, where conventional delivery methods can be unreliable. The aim is to enable larger-scale functional studies in cell types often missing from existing datasets.
Founded in 2025, Aparna Bio is based at Babraham Research Campus near Cambridge.
Company Notes
Member of